SiteOne Raises $100m For Peripheral Nervous System-Targeting Drugs In Pain And More

Lead Asset Competes With Vertex’s NaV1.8 Inhibitor

SiteOne is researching and developing drugs for pain and other conditions (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Scrip